Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/pbc.23252
10.1002/pbc.23252 · External reference
10.3389/fonc.2018.00475
10.3389/fonc.2018.00475 · External reference
10.1038/nrclinonc.2016.200
10.1038/nrclinonc.2016.200 · External reference
10.2217/fon-2016-0499
10.2217/fon-2016-0499 · External reference
10.1001/jama.2020.1707
10.1001/jama.2020.1707 · External reference
10.1155/2010/264360
10.1155/2010/264360 · External reference
Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study
10.1007/s12094-023-03221-6 · 2023 · External reference
10.1097/cco.0b013e3283622d3a
10.1097/cco.0b013e3283622d3a · External reference
10.1016/s0140-6736(12)60651-5
10.1016/s0140-6736(12)60651-5 · External reference
10.1093/annonc/mdx423.001
10.1093/annonc/mdx423.001 · External reference
10.1158/2326-6066.cir-17-0594
10.1158/2326-6066.cir-17-0594 · External reference
10.1016/j.jclinepi.2007.11.008
10.1016/j.jclinepi.2007.11.008 · External reference
10.1126/scisignal.2004088
10.1126/scisignal.2004088 · External reference
10.1158/2159-8290.cd-12-0095
10.1158/2159-8290.cd-12-0095 · External reference
10.1016/j.cell.2017.10.014
10.1016/j.cell.2017.10.014 · External reference
10.1093/nar/gkv1189
10.1093/nar/gkv1189 · External reference
10.1002/cam4.651
10.1002/cam4.651 · External reference
10.18632/oncotarget.10344
10.18632/oncotarget.10344 · External reference
10.3390/cancers11111651
10.3390/cancers11111651 · External reference
10.7717/peerj.7091
10.7717/peerj.7091 · External reference
10.1096/fj.201700237rr
10.1096/fj.201700237rr · External reference
10.3390/cells9051071
10.3390/cells9051071 · External reference
Knockdown of SERPINE1 reverses resistance of triple-negative breast cancer to paclitaxel via suppression of VEGFA
2020 · External reference
10.1161/atvbaha.114.304554
10.1161/atvbaha.114.304554 · External reference
10.1016/j.canlet.2018.10.027
10.1016/j.canlet.2018.10.027 · External reference
10.3233/cbm-150516
10.3233/cbm-150516 · External reference
10.3892/ol.2016.5211
10.3892/ol.2016.5211 · External reference
10.1167/iovs.06-1234
10.1167/iovs.06-1234 · External reference
10.1038/s41598-019-43924-x
10.1038/s41598-019-43924-x · External reference
Urinary protein biomarker panel for the detection of recurrent bladder cancer
10.1158/1055-9965.epi-14-0035 · 2014 · External reference
10.1016/j.biopha.2019.108994
10.1016/j.biopha.2019.108994 · External reference
10.1038/s41523-022-00413-1
10.1038/s41523-022-00413-1 · External reference
10.1038/nri3064
10.1038/nri3064 · External reference
10.3389/fimmu.2018.00978
10.3389/fimmu.2018.00978 · External reference
10.1136/jitc-2020-001561
10.1136/jitc-2020-001561 · External reference
10.1016/s1470-2045(19)30153-6
10.1016/s1470-2045(19)30153-6 · External reference
10.1158/1078-0432.ccr-22-0871
10.1158/1078-0432.ccr-22-0871 · External reference
10.1038/s41392-025-02278-9
10.1038/s41392-025-02278-9 · External reference
10.1016/s1470-2045(18)30081-0
10.1016/s1470-2045(18)30081-0 · External reference
Immune checkpoint inhibitors combined with tyrosine kinase inhibitors for soft-tissue sarcomas: a systematic review and single-arm meta-analysis
2025 · External reference
10.1016/j.celrep.2018.10.082
10.1016/j.celrep.2018.10.082 · External reference
10.3389/fimmu.2024.1487610
10.3389/fimmu.2024.1487610 · External reference
10.1186/s13024-018-0278-0
10.1186/s13024-018-0278-0 · External reference
10.1016/j.taap.2019.01.011
10.1016/j.taap.2019.01.011 · External reference
10.1165/rcmb.2015-0012oc
10.1165/rcmb.2015-0012oc · External reference
10.1158/0008-5472.can-11-4134
10.1158/0008-5472.can-11-4134 · External reference
10.1111/bjd.14727
10.1111/bjd.14727 · External reference
